| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.22 | 6e-06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |